#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Nephropathy Hyperoxaluria Adult T-cell lymphoma/leukaemia refractory Atypical haemolytic uraemic syndrome Spinal muscular atrophy Cluster headache Guillain-Barre syndrome Adrenocortical carcinoma Neonatal alloimmune thrombocytopenia Paraneoplastic neurological syndrome Albright's disease Mucopolysaccharidosis III Autoimmune myositis Idiopathic intracranial hypertension More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Basic Information Wolfram syndrome – Diagnostics Glycogen storage disease type II – Diagnostics Systemic mastocytosis – Treatment Factor IX deficiency – Life with Disease VEXAS syndrome – Trials in Disease Malignant fibrous histiocytoma – Trials in Disease Congenital generalised lipodystrophy – Treatment Alport’s syndrome – Treatment Nephrotic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    TRIACYLGLYCEROL LIPASE Glucagon Dapirolizumab Pegol Clic-1901 Cart Tiotropium Defactinib Vx-264 Relatlimab MAGNESIUM CARBONATE HEAVY Mirabegron Acasunlimab Linaclotide Hct116-B Nepafenac Df6002 68Ganota-Anti-Her2 Vhh1 Ly4100511 YOHIMBINE HYDROCHLORIDE [18F]-Altanserin VX-993 More therapies…

    Learn about Your Condition

    Peritoneal dialysis Aplasia pure red cell Brain stem glioma Plasmablastic lymphoma Sexual dysfunction Head and neck cancer stage IV Open angle glaucoma Genitourinary tract neoplasm Post procedural swelling Double hit lymphoma Primary hypogonadism Mixed-type liposarcoma Metastatic neoplasm Ligament operation Peritoneal abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study Comparing Propylene Glycol and Urea Creams for Treating Dry Feet in People with Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Propylene Glycol
    • Urea
    Sweden

  • Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ly3454738
    • Other Emollients And Protectives
    • Soft Paraffin And Fat Products
    Hungary Italy Poland

  • Study on Apremilast for Patients with Severe Recurrent Mouth Ulcers Resistant to Colchicine

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stomatitis
    Investigated Drugs:
    • Apremilast
    France

  • Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

    Not yet recruiting

    2 1
    Germany Poland Spain

  • Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Antisynthetase syndrome
    • Dermatomyositis
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Daxdilimab
    • Prednisone
    Czechia France Germany Italy Spain

  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Germany Spain
Previous Page
1 … 29 30 31 32 33 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!